APA (7th ed.) Citation

Dimitrakopoulos, F., Mountzios, G., Christopoulos, P., Papastergiou, T., Elshiaty, M., Daniello, L., . . . Kalofonos, H. (2022). Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: Results from a European multicentre study. Therapeutic advances in medical oncology, 14, . https://doi.org/10.1177/17588359221122728

Chicago Style (17th ed.) Citation

Dimitrakopoulos, Foteinos-Ioannis, et al. "Validation of Patras Immunotherapy Score Model for Prediction and Prognosis of Patients with Advanced NSCLC Treated with Nivolumab or Pembrolizumab: Results from a European Multicentre Study." Therapeutic Advances in Medical Oncology 14 (2022). https://doi.org/10.1177/17588359221122728.

MLA (9th ed.) Citation

Dimitrakopoulos, Foteinos-Ioannis, et al. "Validation of Patras Immunotherapy Score Model for Prediction and Prognosis of Patients with Advanced NSCLC Treated with Nivolumab or Pembrolizumab: Results from a European Multicentre Study." Therapeutic Advances in Medical Oncology, vol. 14, 2022, https://doi.org/10.1177/17588359221122728.